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Abstract
Introduction:  Liver  resection  has  been  associated  with  high  morbidity  and  mortality,  and  the
most serious  complication  is  liver  failure.  Patient  evaluation  is  limited  to  risk  scales.  The  50-50
criteria and  bilirubin  peak  >  7  mg/dl  have  been  used  as  mortality  predictors.
Aim: The  aim  of  this  study  was  to  determine  the  risk  factors  associated  with  morbidity  and
mortality  for  liver  resection  in  our  population.
Material  and  methods:  A  retrospective  study  was  carried  out  on  51  patients  that  underwent
liver resection.  Sociodemographic  variables,  pathology,  and  the  surgical  act  were  analyzed,
together  with  morbidity  and  mortality  and  their  associated  factors.
Results:  Fifty-one  patients,  23  men  and  28  women,  were  analyzed.  They  had  a  mean  age  of
51.4 ±  19.13  years,  64.7%  had  concomitant  disease,  and  their  mean  MELD  score  was  7.49  ±  1.79.
The mean  size  of  the  resected  lesions  was  7.34  ±  3.47  cm,  51%  were  malignant,  and  34  minor
resections  were  performed.  The  Pringle  maneuver  was  used  in  64.7%  of  the  cases  and  the
mean blood  loss  was  1,090  ±  121.76  ml.  Morbidity  of  25.5%  was  associated  with  viral  hepatitis
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infection,  greater  blood  loss,  transfusion  requirement,  the  Pringle  maneuver,  lower  hemoglobin
and PTT  values,  and  higher  MELD,  INR,  bilirubin,  and  glucose  values.  A  total  3.9%  mortality  was
associated  with  hyperbilirubinemia,  hyperglycemia,  and  greater  blood  loss  and  transfusions.
Conclusions:  The  main  risk  factors  associated  with  the  morbidity  and  mortality  of  liver  resection
in our  population  were  those  related  to  the  preoperative  biochemical  parameters  of  the  patient
and the  factors  that  occurred  during  the  surgical  act.
© 2016  Asociacio´n  Mexicana  de  Gastroenterolog´ıa.  Published  by  Masson  Doyma  Me´xico  S.A.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Morbilidad,  mortalidad  y  factores  de  riesgo  de  la  cirugía  hepática  en  los
departamentos  de  cirugía  hepatobiliar  de  Veracruz,  México
Resumen
Antecedentes:  La  resección  hepática  se  asocia  con  una  alta  morbilidad  y  mortalidad,  siendo
la insuﬁciencia  hepática  la  complicación  más  grave.  La  evaluación  de  los  pacientes  se  limita
a analizar  las  escalas  de  riesgo.  Los  criterios  50-50  y  el  pico  de  bilirrubina  >7  mg/dl  han  sido
utilizados  como  predictores  de  mortalidad.
Objetivo:  Determinar  los  factores  de  riesgo  asociados  a  la  morbilidad  y  mortalidad  asociada  a
resecciones hepáticas  en  nuestra  población.
Material  y  métodos: Estudio  retrospectivo  en  51  pacientes  sometidos  a  resecciones  hepáticas.
Se analizaron  variables  sociodemográﬁcas;  la  patología  y  el  acto  quirúrgico;  la  morbilidad  y
mortalidad,  y  los  factores  asociados  a  estas.
Resultados:  Se  analizaron  51  pacientes,  23  hombres  y  28  mujeres,  con  edad  promedio  de
51.4 ±  19.13  an˜os,  patología  concomitante  en  el  64.7%,  MELD  promedio  de  7.49  ±  1.79.  Se
resecaron  lesiones  con  un  taman˜o  de  7.34  ±  3.47  cm,  un  51%  de  ellas  malignas,  34  resecciones
menores  y  se  realizó  la  maniobra  de  Pringle  en  un  64.7%  de  los  casos,  con  una  pérdida  sanguínea
promedio  de  1,090  ±  121.76  ml.  Se  encontró  una  morbilidad  del  25.5%  asociada  a  la  presencia
de HV,  a  la  mayor  pérdida  sanguínea,  a  las  transfusiones,  a  la  realización  de  la  maniobra  de
Pringle, a  los  valores  de  hemoglobina  y  TPT  menores,  a  los  valores  de  MELD,  de  INR,  de  bilirru-
bina y  glucosa  mayores.  Se  encontró  una  mortalidad  del  3.9%  asociada  a  la  hiperbilirrubinemia,
hiperglucemia,  mayor  pérdida  sanguínea  y  transfusiones.
Conclusiones:  Los  factores  de  riesgo  asociados  a  la  morbilidad  y  mortalidad  en  las  resecciones
hepáticas de  nuestra  población  se  asocian  principalmente  a  los  parámetros  bioquímicos  preo-
peratorios  del  paciente,  y  a  los  factores  que  ocurren  durante  la  intervención  quirúrgica.
© 2016  Asociacio´n  Mexicana  de  Gastroenterolog´ıa.  Publicado  por  Masson  Doyma  Me´xico  S.A.
Este es  un  art´ıculo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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istorically,  liver  resection  has  been  associated  with  peri-
perative  mortality  of  10  to  20%  and  with  morbidity  after
epatectomy  of  20  to  40%.  Advances  in  perioperative
anagement  and  surgical  techniques  have  improved  the
ortality  ranges,  but  morbidity  has  remained  high.1--7
Current  efforts  to  evaluate  the  postoperative  course
f  the  patients  have  been  almost  exclusively  limited  to
reoperative  assessment,  primarily  including  biochemical
arameters  (serum  bilirubin,  prothrombin  time,  and  albumin
evels)  and  clinical  risk  scales,  such  as  the  Child-Turcotte-
ugh  (CTP)  and  the  model  for  end-stage  liver  disease  (MELD).
reoperative  parameters  can  be  useful  to  determine  the
election  criteria  for  surgery  and  postoperative  risk  strat-
ﬁcation.  Post-hepatectomy  liver  failure  is  the  most  serious
omplication,  deﬁned  as  the  increase  in  the  international
p
t
rormalized  ratio  (INR)  and  hyperbilirubinemia  at  or  after
ostoperative  day  5,  providing  a  severity  grade.  Its  incidence
aries  from  1.2%  to  32%.1,8--19
The  ‘‘50-50  criterion’’  has  been  suggested  for  predicting
ost-hepatectomy  liver  failure  and  death  in  intensive  care
nits,  and  has  been  deﬁned  as  concomitant  prothrombin
ime  (PT)  <50%  and  serum  bilirubin  >50  mol/l  (2.92  mg/dl).
atients  presenting  with  this  criterion  have  a 59%  risk  for
eath  and  it  is  regarded  as  an  indicator  of  post-hepatectomy
iver  failure.  In  contrast,  some  researchers  have  defended
 bilirubin  peak  >7  mg/dl  as  a  more  speciﬁc  predictor  of
ost-hepatectomy  mortality.7
Risk  factor  identiﬁcation  is  important  for  reducing  the
ncidence  of  morbidity  and  mortality  associated  with  this
rocedure.  The  aim  of  the  present  study  was  to  determine
he  risk  factors  associated  with  morbidity  and  mortality  in
elation  to  liver  resection  in  our  population.
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FLiver  resection  morbidity,  mortality,  and  risk  factors  in  Vera
Materials and methods
A  retrospective,  cross-sectional,  analytic  study  was  con-
ducted  on  51  patients  with  complete  case  records  that  were
above  18  years  of  age  and  underwent  liver  resection  within
the  time  frame  of  January  1,  2008  and  May  31,  2015,  at
the  hepatobiliary  surgery  services  of  the  Unidad  Médica  de
Alta  Especialidad, Hospital  de  Especialidades  No  14  Centro
Médico  Nacional  ‘‘Adolfo  Ruiz  Cortinez’’,  Instituto  Mexi-
cano  del  Seguro  Social, Veracruz,  Mexico  and  the  Hospital
de  Alta  Especialidad  de  Veracruz,  Veracruz,  Mexico.  The
study  protocol  was  authorized  by  the  research  and  ethics
committees  of  the  hospitals.
The  data  collected  on  each  patient  included  the  sociode-
mographic  variables  of  age,  sex,  and  body  mass  index  (BMI),
the  presence  of  concomitant  disease  (diabetes  mellitus,
high  blood  pressure,  cirrhosis  of  the  liver,  and  viral  hep-
atitis),  preoperative  chemotherapy,  and  the  MELD  score
utilizing  creatinine,  total  bilirubin,  INR,  and  dialysis  during
the  past  week.1 Preoperative  laboratory  values  were  also
determined:  hemoglobin,  hematocrit,  leukocytes,  platelets,
glucose,  blood  urea  and  nitrogen  (BUN),  urea,  creati-
nine,  PT,  partial  thromboplastin  time  (PTT),  INR,  alanine
aminotransferase  (ALT),  aspartate  aminotransferase  (AST),
alkaline  phosphatase  (ALP),  total  bilirubin,  direct  bilirubin,
indirect  bilirubin,  total  protein,  albumin,  and  globulin.  The
analyzed  variables  related  to  the  lesion  were:  size,  location,
benignity  or  malignancy,  and  primary  lesions  vs  metastatic
ones.  The  variables  corresponding  to  surgery  were:  resection
extension  (more  than  three  segments  was  considered  major
resection),1 the  Pringle  maneuver  and  the  time  it  took  to
perform  it,  surgery  duration,  intraoperative  blood  loss  and
the  number  of  packed  red  blood  cell  units  transfused,  the
postoperative  progression  of  the  patient  taking  into  account
admission  to  the  intensive  care  unit  and  the  number  of  days
spent  there,  liver  failure,  the  50-50  criterion,  bilirubin  peak
>7  mg/dl,  surgical  reintervention,  days  of  hospital  stay,  and
morbidity  and  mortality.
Statistical  analysis
The  statistical  analysis  of  the  continuous  and  discrete
variables  was  measured  in  means  and  standard  deviation.
The  categorical  variables  were  measured  in  frequencies
and  percentages.  The  preoperative,  intraoperative,  and
postoperative  variables  correlated  with  morbidity  and
mortality  were  identiﬁed  through  bivariate  analysis.  The
categorical  variables  were  evaluated  using  the  chi-square
test  and/or  Fisher’s  exact  test  with  odds  ratio  (OR)  and
relative  risk.  The  continuous  variables  were  evaluated  using
the  Student’s  t  test  for  the  parametric  variables  and  the
Mann-Whitney  U  test  for  the  nonparametric  variables.  The
statistically  signiﬁcant  laboratory  parameters  for  morbidity
and  mortality  were  categorized  into  normal  and  abnormal
values,  carrying  out  the  OR  to  establish  the  relative  risk
based  on  the  alteration  of  those  parameters.  ROC  curves
were  plotted  to  establish  areas  under  the  curve  with  a
power  of  prediction  above  0.70,  sensitivity,  speciﬁcity,
and  cut-off  points  in  the  laboratory  parameters  that  were
statistically  signiﬁcant.  They  were  then  re-categorized
from  the  cut-off  points  and  the  ORs  and  relative  risks  were
T
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alculated.  Statistical  signiﬁcance  was  set  at  a  p  below  0.05
nd  the  SPSS  version  21  software  was  used  for  the  analysis.
esults
 total  of  51  patients  were  analyzed,  23  of  whom  (45.1%)
ere  women  and  28  (54.9%)  were  men.  Their  mean  age
as  51.47  ±  19.13  years,  mean  weight  70.1  ±  10.31  kilo-
rams,  mean  height  1.62  ±  0.07  meters,  and  a BMI  of
6.65  ±  4.19  kg/m2. Thirty-three  (64.7%)  of  the  patients
resented  with  concomitant  disease,  29  of  whom  (56.9%)
ad  diabetes  mellitus,  30  (58.8%)  had  high  blood  pressure,  5
9.8%)  had  viral  hepatitis,  8  (15.7%)  presented  with  cirrhosis
f  the  liver,  and  13.7%  received  preoperative  chemotherapy.
he  mean  MELD  score  was  7.49  ±  1.79  and  all  the  patients
hat  presented  with  cirrhosis  of  the  liver  were  classiﬁed  as
hild-Pugh  A.
The  means  of  the  preoperative  laboratory  results  were
emoglobin  13.5  ±  1.25  mg/dl,  hematocrit  39.37  ±  3.86%,
eukocyte  count  7,654.06  ±  3,241.43,  platelets  245,111  ±
7,575.81,  glycemia  95.91  ±  17.39  mg/dl,  blood  urea  and
itrogen  19.19  ±  16.61  mg/dl,  urea  29.14  ±  14.76,  and  cre-
tinine  0.98  ±  0.37.  The  mean  coagulation  test  results  were
T  12.86  ±  1.88,  PTT  27.77  ±  3.19,  and  the  mean  INR  was
.05  ±  0.13.  The  mean  liver  function  test  results  were  ALT
2.56  ±  217.94,  AST  57.6  ±  88.34,  ALP  40.95  ±  103.37,  and
s  means,  total  bilirubin  was  0.92  ±  1.14,  direct  bilirubin
as  0.59  ±  1.09,  indirect  bilirubin  was  0.4  ±  0.26,  total  pro-
ein  was  6.97  ±  1.02,  albumin  was  4.02  ±  0.73,  and  globulin
as  3.23  ±  1.05.
The  mean  size  of  the  resected  lesions  was  7.34  ±  3.47  cm,
he  majority  of  which  were  located  in  the  right  hepatic  lobe
54.9%).  Malignant  tumors  were  found  in  26  (51%)  cases,
f  which  16  (31.4%)  were  primary  tumors  and  10  (19.6%)
ere  metastatic  tumors.  Thirty-four  (66.7%)  of  the  resec-
ions  performed  were  minor,  16  in  the  right  hepatic  lobe  and
8  in  the  left  hepatic  lobe.  A  total  of  17  (33.3%)  were  major
esections,  12  right  hemihepatectomies  and  5  left  hemihep-
tectomies.  The  Pringle  maneuver  was  used  in  64.7%  of  the
esections,  with  a  mean  duration  of  18.54  ±  7.33  min,  mean
urgery  time  was  211.27  ±  57.76  min,  mean  blood  loss  was
,090  ±  1,217.26  ml,  and  mean  packed  red  blood  cell  unit
ransfusion  was  2.29  ±  2.51.
In  regard  to  postoperative  progression,  22  (43.1%)
atients  were  admitted  to  the  intensive  care  unit  with
 mean  stay  of  1.37  ±  2.24  days.  Eight  (15.7%)  patients
ad  post-hepatectomy  liver  failure,  4  (7.8%)  patients  had
 positive  50-50  criterion,  and  8  (15.7%)  patients  had  a
ilirubin  peak  >7  mg/dl.  Three  cases  required  surgical  rein-
ervention  with  a  reported  mean  hospital  stay  of  8.62  ±
.74  days.  The  incidence  of  morbidity  was  25.5%  and  cor-
esponded  to  liver  failure  in  7  patients  and  to  hernia  of
he  wall,  bleeding,  surgical  wound  infection,  and  a  cere-
ral  vascular  event  (n  =  1  each).  The  reported  mortality  was
.9%  (n  =  2).
actors  associated  with  morbidityhe  patients  that  had  the  highest  morbidity  rate  had  sig-
iﬁcantly  lower  hemoglobin  values  and  shorter  PTT  than
hose  that  did  not  present  with  morbidity.  The  MELD  score
198  G.  Martínez-Mier  et  al.
Table  1  Parameters  associated  with  morbidity.
Parameter  Morbidity
(mean  ±  SD  or  %)
No  morbidity
(mean  ±  SD  or  %)
p  Cut-off
point
AUC  Sensitivity
(%)
Speciﬁcity
(%)
Hemoglobin  (mg/dl)  12.35  ±  1.07  13.26  ±  1.24  0.04*  ****  ****  ****  ****
PTT  25.81  ±  3.75  28.37  ±  2.80  0.03*  ****  ****  ****  ****
INR  1.13  ±  0.17  1.02  ±  0.1  0.01*  ****  ****  ****  ****
MELD  8.76  ±  3.16  7.05  ±  1.43  0.002* 7.5  0.74  76.9  77.8
Total bilirubin
(mg/dl)
1.36  ±  1.71  0.76  ±  0.84  0.004** 0.73  0.72  84.6  71.8
Direct bilirubin
(mg/dl)
1.19  ±  1.57  0.40  ±  0.85  0.001** 0.37  0.902  84.6  71.8
Glucose (mg/dl) 108.7  ±  24.27 92.25  ±  13.17 0.02** 96.5 0.73 80  63.9
Blood loss  (mL) 2397.27  ±
1575.01
701.35  ±  753.64 0.001** 1010  0.86 81.8 84.2
Packed red  blood  cell
units  transfused
(number)
4.84  ±  2.70  1.42  ±  1.76  0.0001** 2.5  0.86  76.9  84.2
Viral hepatitis  80%  20%  0.01*** -  -  -  -
Pringle maneuver  92.30%  7.70%  0.01*** -  -  -  -
AUC: area under the curve; MELD: model for end-stage liver disease; INR: international normalized ratio; PTT: partial thromboplastin
time; SD: standard deviation.
* Value obtained through the Student’s t test.
** Value obtained through the Mann-Whitney U test.
*** Value obtained through the chi-square test.
**** No statistically signiﬁcant data were found in the ROC curve analysis.
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ences  in  the  comparison  of  abnormal  total  bilirubin,  directith  a  worse  prognosis  was  also  reported  in  the  patients
hat  presented  with  morbidity,  as  well  as  increased  levels
f  INR,  total  bilirubin,  direct  bilirubin,  and  glucose.  In  addi-
ion,  the  patients  with  greater  morbidity  had  greater  blood
oss  and  a  higher  mean  transfusion  requirement.  Among
he  comorbidities,  the  patients  with  viral  hepatitis  had  a
igher  complication  rate.  Signiﬁcantly  higher  morbidity  was
lso  found  in  the  patients  that  had  the  Pringle  maneuver.
able  1 shows  the  corresponding  data.  Analyses  of  the  statis-
ically  signiﬁcant  factors  were  done  through  ROC  curves  and
howed  the  following  cut-off  points:  MELD  score  7.5  points
p  =  0.004),  total  bilirubin  0.73  mg/dl  (p  =  0.004),  direct
ilirubin  0.37  mg/dl  (p  =  0.00),  glucose  levels  96.5  mg/dl  (p
 0.02),  packed  red  blood  cell  units  2.5  (p  =  0.00),  and  intra-
perative  blood  loss  1,010  ml  (p  =  0.001).  Table  1  shows  the
ensitivity,  speciﬁcity,  and  area  under  the  curve  (AUC)  of  the
tatistically  signiﬁcant  factors.
The  OR  and  relative  risk  analyses  identiﬁed  viral  hepati-
is  (OR:  4.17)  (p  =  0.01)  and  the  Pringle  maneuver  (OR:  6.35)
p  =  0.01)  as  risk  factors  for  presenting  with  complications.
ormal  glucose  levels  were  associated  with  not  having
omplications  (OR:  1.53)  (p  =  0.04).  We  observed  a  trend
or  normal  INR,  total  bilirubin,  and  direct  bilirubin  (OR:
.61)  (p  =  0.057),  (OR:  1.86)  (p  =  0.056),  and  (OR:  1.52)
p  =  0.052),  respectively,  to  be  factors  associated  with  the
bsence  of  morbidity.  Likewise,  levels  under  the  cut-off
oint  obtained  in  the  ROC  curves  were  associated  with  the
bsence  of  complications:  MELD  (OR:  1.71)  (p  =  0.04),  total
ilirubin  (OR:  1.86)  (p  =  0.001),  direct  bilirubin  (OR:  1.72)
p  = 0.001),  glucose  (OR:  1.55)  (p  =  0.01),  blood  loss  (OR:
b
t
o.42)  (p  =  0.001),  and  blood-derived  transfusions  (OR:  4.96)
p  = 0.001)  (ﬁg.  1).
actors  associated  with  mortality
erioperative  mortality  in  the  present  study  was  associated
ith  higher  preoperative  values  of  total  bilirubin,  direct
ilirubin,  and  glucose.  Blood  loss  and  a  greater  number  of
ransfusions  were  associated  with  mortality.  Table  2  shows
he  corresponding  data.  Neither  the  50-50  criterion  nor  the
ilirubin  peak  >  7  mg/dl  was  associated  with  mortality  (p  =
.67  y  p  =  0.29,  respectively).
The  ROC  curve  analysis  found  that  total  bilirubin  had  an
UC  of  0.87  (95%  conﬁdence  interval  [95%  CI]  0.75  --  0.99)
p  =  0.07)  with  100%  sensitivity  and  78%  speciﬁcity  when
here  were  values  above  0.88  mg/dl.  Direct  bilirubin  had  an
UC  of  0.85  (95%  CI  0.71  --  0.99)  (p  =  0.09),  100%  sensitivity
nd  75.6%  speciﬁcity,  with  a  cut-off  point  of  0.49  mg/dl.  The
umber  of  packed  red  blood  cell  units  transfused  had  an  AUC
f  0.91  (95%  CI  0.78  --  1.00)  (p  =  0.04),  corresponding  to  100%
ensitivity  and  82%  speciﬁcity  when  3.5  or  more  packed  red
lood  cell  units  were  transfused.  Blood  loss  had  an  AUC  of
.97  (95%  CI  0.92  --  1.00)  (p  =  0.02),  100%  sensitivity,  93.6%
peciﬁcity,  and  a  cut-off  point  of  3,250  ml.
The  relative  risk  analysis  found  no  signiﬁcant  differ-ilirubin,  and  glucose  levels.  When  the  cut-off  points  of
he  variables  were  compared,  having  received  a  number
f  packed  red  blood  cell  units  lower  than  the  cut-off  point
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(OR:  1.22  0.92  --  1.61)  (p  =  0.04)  was  shown  to  be  a  protec-
tive  factor.  The  rest  of  the  variables  showed  no  statistically
signiﬁcant  difference.
Discussion
Our  study  results  reﬂected  the  fact  that  morbidity  and
mortality  in  liver  resection  in  this  population  were  mainly
associated  with  risk  factors  related  to  the  clinical  status  of
the  patient  prior  to  surgery  and  to  factors  involved  in  the
intraoperative  period.
The  incidence  of  morbidity  in  our  study  was  25.2%,  similar
to  that  published  in  the  literature,  in  which  ranges  vary  from
14  to  43%  in  multicenter  studies,  as  well  as  those  from  single
centers,  with  a  variable  number  of  patients  that  was  both
higher  and  lower  than  ours.1,4,5,10,12,19 The  most  common
complications  after  a  liver  resection  in  order  of  frequency
are  biliary  leaks,  infections,  collections,  bleeding,  and  liver
failure.1,5,10--12 In  our  study,  liver  failure  was  the  most  fre-
quent  complication  (13.7%),  being  somewhat  higher  than  the
published  ﬁgures  that  range  from  0.5%  to  2%.5,10
t
f
t
a
Table  2  Parameters  associated  with  mortality.
Parameter  Mortality  (
Total  bilirubin  (mg/dl)  1.18  ±  0.
Direct  bilirubin  (mg/dl)  0.75  ±  0.
Glucose  (mg/dl)  102.5  ±  27
Blood  loss  (mL)  4250  ±  10
Packed  red  blood  cell  units  transfused  (number)  7  ±  4.
SD: standard deviation.
* Values obtained through the Mann-Whitney U test.ors  associated  with  morbidity.
The  Pringle  maneuver  was  shown  to  be  a  decisive  vari-
ble  in  relation  to  morbidity.  However,  in  some  studies
here  is  only  an  association  when  the  maneuver  takes  more
han  20  min,  thus  being  associated  with  cellular  edema,
ymphatic  system  drainage  disruption,  pleural  effusion,
bscesses,  hemoperitoneum,  and  transitory  liver  failure,
hich  was  not  the  case  in  our  results.20,21 Glucose  and  biliru-
in  levels  and  coagulation  alterations,  as  well  as  the  use
f  blood  products,  are  associated  with  a  higher  complica-
ion  rate.1,4,5,10--12,19--21 Some  risk  factors  that  are  associated
ith  morbidity,  such  as  the  risk  factors  of  chronic  degener-
tive  diseases  (diabetes  mellitus,  high  blood  pressure,  and
irrhosis  of  the  liver),  were  not  found  to  be  associated  with
omplications  in  our  study.  The  malignant  strain  of  resected
esions  has  sometimes  been  associated  with  a greater  risk
or  morbidity, 1,5,20 but  that  was  not  the  case  in  our  study.
There  are  different  scales  that  evaluate  the  biochemical
arameters  of  the  patient  to  arrive  at  a  survival  predic-
ion,  such  as  the  MELD  scoring  system,  which  was  created
or  patients  that  were  candidates  for  transjugular  portosys-
emic  intrahepatic  shunts.  Few  studies  associate  morbidity
nd  mortality  with  liver  resection  and  in  the  existing  ones
mean  ±  SD)  No  mortality  (mean  ±  SD)  p
39  0.91  ±  1.16  0.004*
36  0.58  ±  1.12  0.0001*
.57  95.6  ±  17.22  0.02*
60.66  952.60  ±  1029.31  0.001*
24  2.1  ±  2.29  0.0001*
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here  is  a  positive  predictive  value  for  the  presence  of
omplications  with  values  above  8  and  a  predictive  value  for
ortality  with  values  above  10.1,5 In  our  results,  patients
hat  had  a  higher  preoperative  MELD  score  (8.7),  had  a
igher  complication  rate,  but  we  found  no  similar  associ-
tion  in  relation  to  mortality.
Our  relative  risk  and  odds  ratio  analysis  showed  there  was
 risk  for  presenting  with  complications  when  the  Pringle
aneuver  was  used  and  the  patient  was  a  carrier  of  viral
epatitis.  Viral  hepatitis  has  been  associated  with  both  an
ncidence  of  surgical  site  infections  and  a  reactivation  of  the
irus,  which  can  lead  to  severe  liver  damage  and  patient
eath  after  a  liver  resection.22,23 Normal  range  biochemi-
al  parameters  are  protective  factors  for  the  presence  of
orbidity,  but  not  for  mortality,  which  had  no  signiﬁcant
ssociation  in  relation  to  abnormal  values  or  the  cut-off
oint.  Other  studies  state  that  patients  with  an  increased
NR  are  at  greater  risk  for  death.  In  our  ﬁndings,  altered
NR  values  conferred  no  risk  for  presenting  with  mortal-
ty,  but  normal  values  inferred  protection  for  morbidity.5
yperbilirubinemia  was  a  risk  for  morbidity  similar  to  others,
nlike  the  results  of  larger  studies.1,5,8 We  also  found  that
he  number  of  packed  red  blood  cell  units  transfused  in  our
opulation  had  a  signiﬁcant  risk  for  death  when  it  exceeded
.5  units  (OR  1.22).  Nevertheless,  our  risk  was  lower  and
he  number  of  units  was  also  lower  than  those  reported  by
ancaster  et  al.19 in  which  there  was  an  OR  of  11.63  with
he  transfusion  of  more  than  4  packed  red  blood  cell  units.
The  mortality  of  our  series  was  acceptable  in  accordance
ith  current  studies  in  which  it  ranges  from  0.5%  to  6%.  We
lso  found  that  the  factors  associated  with  it  (hyperbiliru-
inemia,  hyperglycemia,  and  the  use  of  blood  products)
ave  previously  been  described  by  other  authors.1 The  50-50
riterion  was  not  applicable  in  our  study,  nor  did  the  biliru-
in  peak  >  7  mg/dl  on  day  ﬁve  show  predictive  value  for
ortality  in  our  population,  contrasting  with  other  studies
hat  consider  it  an  important  predictor.1 This  could  be  due
o  the  small  size  of  our  sample  and  the  low  mortality  rate.
There  are  very  few  Mexican  case  series  in  the  literature
hat  describe  the  complication  and  mortality  rates  of  liver
urgery  in  our  country.24--27 One  of  them  is  over  20  years
ld  and  reports  on  67  patients  over  a  10-year  period.27
he  complication  rate  varies  from  16  to  33%,24--26 with  a
ecent  mortality  rate  (after  2009)  below  13%,24 and  there-
ore,  with  respect  to  our  study,  it  is  difﬁcult  to  establish
imilarities  or  differences  at  the  national  level.  Our  results
re  from  a  small  case  series  with  a  retrospective  review  of
he  medical  records,  which  could  explain  why  no  signiﬁcant
ssociation  was  found  between  the  current  mortality  criteria
hat  include  the  50-50  criterion  and  the  bilirubin  peak  above
 mg/dl.  Our  results  reﬂect  the  parameters  of  international
tandards  of  efﬁcacy  and  safety  and  we  found  factors  tra-
itionally  associated  with  perioperative  complications  and
eath  in  liver  surgery.
onclusionshe  risk  factors  associated  with  morbidity  and  mortality  in
iver  resection  in  our  population  are  mainly  associated  with
he  preoperative  biochemical  parameters  of  the  patient  and
ith  the  factors  that  occur  during  the  surgical  act.
1G.  Martínez-Mier  et  al.
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